Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Vaxil Bio financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-29
Market Capitalization
$1.4 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CAD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating expense total | 985.0K | 839.0K | 805.0K | 635.0K | 392.0K | 259.0K | 196.0K | 179.0K |
| Depreciation and amortization | 56.0K | 100.0K | 57.0K | 25.0K | 2.0K | |||
| EBITDA | (985.0K) | (839.0K) | (805.0K) | (635.0K) | (392.0K) | (259.0K) | (196.0K) | (179.0K) |
| EBIT | (1.0M) | (939.0K) | (862.0K) | (660.0K) | (394.0K) | (259.0K) | (196.0K) | (179.0K) |
| Interest income | 18.0K | 87.0K | ||||||
| Interest expense | 6.0K | 11.0K | 11.0K | |||||
| Pre tax profit | (1.0M) | (1.2M) | (1.4M) | (986.0K) | (584.0K) | (254.0K) | (178.0K) | 521.0K |
| Net Income | (1.0M) | (1.2M) | (1.4M) | (986.0K) | (584.0K) | (254.0K) | (178.0K) | 521.0K |